Pomanda estimates the enterprise value of FIOS GENOMICS LIMITED at £6.2m based on a Turnover of £4.2m and 1.47x industry multiple (adjusted for size and gross margin).
fios genomics limitedEstimated Valuation
£303.6k
Pomanda estimates the enterprise value of FIOS GENOMICS LIMITED at £303.6k based on an EBITDA of £52.2k and a 5.81x industry multiple (adjusted for size and gross margin).
fios genomics limitedEstimated Valuation
£4.2m
Pomanda estimates the enterprise value of FIOS GENOMICS LIMITED at £4.2m based on Net Assets of £2.3m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fios Genomics LimitedOverview
Fios Genomics Limited is a live company located in edinburgh, EH16 4UX with a Companies House number of SC341432. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2008, it's largest shareholder is
scottish enterprise
with a 20.5% stake. Fios Genomics Limited is a established,
small sized company, Pomanda has estimated its turnover at
£4.2m with
high
growth in recent years.
Pomanda's financial health check has awarded Fios Genomics Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
3 Strong
6 Regular
2 Weak
Size
annual sales of £4.2m, make it in line with the average company (£3.8m)
£4.2m - Fios Genomics Limited
£3.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a similar rate (13.3%)
16% - Fios Genomics Limited
13.3% - Industry AVG
Production
with a gross margin of 56.8%, this company has a comparable cost of product (56.8%)
56.8% - Fios Genomics Limited
56.8% - Industry AVG
Profitability
an operating margin of -1.4% make it more profitable than the average company (-7.8%)
-1.4% - Fios Genomics Limited
-7.8% - Industry AVG
Employees
with 48 employees, this is similar to the industry average (47)
48 - Fios Genomics Limited
47 - Industry AVG
Pay Structure
on an average salary of £82.6k, the company has an equivalent pay structure (£82.6k)
£82.6k - Fios Genomics Limited
£82.6k - Industry AVG
Efficiency
resulting in sales per employee of £86.9k, this is less efficient (£130.8k)
£86.9k - Fios Genomics Limited
£130.8k - Industry AVG
Debtor Days
it gets paid by customers after 52 days, this is near the average (54 days)
52 days - Fios Genomics Limited
54 days - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (57 days)
2 days - Fios Genomics Limited
57 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Fios Genomics Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 98 weeks, this is more cash available to meet short term requirements (32 weeks)
98 weeks - Fios Genomics Limited
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 16%, this is a lower level of debt than the average (50.8%)
16% - Fios Genomics Limited
50.8% - Industry AVG
FIOS GENOMICS LIMITED financials
EXPORT
Fios Genomics Limited's latest turnover from April 2024 is estimated at £4.2 million and the company has net assets of £2.3 million. According to their latest financial statements, Fios Genomics Limited has 48 employees and maintains cash reserves of £780.2 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Apr 2014
Apr 2013
Apr 2012
Apr 2011
Apr 2010
Turnover
4,170,499
3,067,566
3,598,037
2,683,756
2,078,465
1,587,135
1,899,235
1,494,754
721,847
540,238
273,607
462,365
208,328
340,432
103,537
Other Income Or Grants
Cost Of Sales
1,801,582
1,351,717
1,749,147
1,279,771
993,107
778,851
878,927
750,325
396,307
296,738
144,541
252,845
114,538
171,404
46,516
Gross Profit
2,368,918
1,715,849
1,848,891
1,403,984
1,085,358
808,284
1,020,308
744,430
325,539
243,500
129,066
209,520
93,790
169,028
57,021
Admin Expenses
2,425,479
1,415,921
1,845,003
1,007,668
1,108,796
1,131,073
251,556
316,472
440,798
402,431
549,035
535,866
368,459
194,211
95,112
Operating Profit
-56,561
299,928
3,888
396,316
-23,438
-322,789
768,752
427,958
-115,259
-158,931
-419,969
-326,346
-274,669
-25,183
-38,091
Interest Payable
Interest Receivable
31,246
39,170
11,956
1,729
1,368
8,635
4,408
1,205
1,416
250
178
892
1,090
367
Pre-Tax Profit
-25,315
339,097
15,844
398,044
-22,070
-314,154
773,160
429,163
-113,843
-158,681
-419,791
-325,454
-273,579
-24,816
-38,091
Tax
-84,774
-3,010
-75,628
-146,900
-81,541
Profit After Tax
-25,315
254,323
12,834
322,416
-22,070
-314,154
626,260
347,622
-113,843
-158,681
-419,791
-325,454
-273,579
-24,816
-38,091
Dividends Paid
Retained Profit
-25,315
254,323
12,834
322,416
-22,070
-314,154
626,260
347,622
-113,843
-158,681
-419,791
-325,454
-273,579
-24,816
-38,091
Employee Costs
3,964,849
3,282,232
3,382,489
2,589,716
1,981,667
1,755,500
1,378,540
1,103,203
682,877
328,649
158,536
259,083
159,827
207,234
50,413
Number Of Employees
48
43
44
37
29
26
22
19
12
6
3
5
3
4
1
EBITDA*
52,247
408,793
48,110
423,386
2,093
-285,989
805,936
459,115
-98,191
-148,047
-414,544
-325,447
-272,842
-23,356
-36,343
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Apr 2014
Apr 2013
Apr 2012
Apr 2011
Apr 2010
Tangible Assets
176,439
266,037
331,178
55,628
28,918
32,817
48,184
58,849
52,928
25,298
14,564
1,763
1,673
1,749
3,103
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
176,439
266,037
331,178
55,628
28,918
32,817
48,184
58,849
52,928
25,298
14,564
1,763
1,673
1,749
3,103
Stock & work in progress
Trade Debtors
595,647
294,853
406,876
387,638
250,194
139,604
303,945
273,791
65,868
65,390
15,913
24,401
6,514
20,216
13,039
Group Debtors
Misc Debtors
216,705
266,244
217,518
314,492
199,271
115,825
182,292
184,363
73,340
Cash
780,193
410,112
1,433,160
1,755,119
1,702,728
1,034,018
1,268,662
494,586
469,611
96,646
3,522
67,654
289,305
146,689
misc current assets
1,007,589
1,563,615
total current assets
2,600,134
2,534,824
2,057,554
2,457,249
2,152,193
1,289,447
1,754,899
952,740
608,819
162,036
19,435
92,055
295,819
166,905
13,039
total assets
2,776,573
2,800,861
2,388,732
2,512,877
2,181,111
1,322,264
1,803,083
1,011,589
661,747
187,334
33,999
93,818
297,492
168,654
16,142
Bank overdraft
Bank loan
Trade Creditors
10,660
53,771
21,161
15,116
76,727
36,251
38,734
7,211
34,012
166,873
134,627
247,231
125,451
223,034
52,566
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
399,334
371,580
262,764
408,578
337,593
209,374
373,556
239,845
210,824
total current liabilities
409,994
425,351
283,925
423,694
414,320
245,625
412,290
247,056
244,836
166,873
134,627
247,231
125,451
223,034
52,566
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
35,490
19,110
2,730
total long term liabilities
35,490
19,110
2,730
total liabilities
445,484
444,461
286,655
423,694
414,320
245,625
412,290
247,056
244,836
166,873
134,627
247,231
125,451
223,034
52,566
net assets
2,331,089
2,356,400
2,102,077
2,089,183
1,766,791
1,076,639
1,390,793
764,533
416,911
20,461
-100,628
-153,413
172,041
-54,380
-36,424
total shareholders funds
2,331,089
2,356,400
2,102,077
2,089,183
1,766,791
1,076,639
1,390,793
764,533
416,911
20,461
-100,628
-153,413
172,041
-54,380
-36,424
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Apr 2014
Apr 2013
Apr 2012
Apr 2011
Apr 2010
Operating Activities
Operating Profit
-56,561
299,928
3,888
396,316
-23,438
-322,789
768,752
427,958
-115,259
-158,931
-419,969
-326,346
-274,669
-25,183
-38,091
Depreciation
108,808
108,865
44,222
27,070
25,531
36,800
37,184
31,157
17,068
10,884
5,425
899
1,827
1,827
1,748
Amortisation
Tax
-84,774
-3,010
-75,628
-146,900
-81,541
Stock
Debtors
251,255
-63,297
-77,736
252,665
194,036
-230,808
28,083
318,946
73,818
49,477
-8,488
17,887
-13,702
7,177
13,039
Creditors
-43,111
32,610
6,045
-61,611
40,476
-2,483
31,523
-26,801
-132,861
32,246
-112,604
121,780
-97,583
170,468
52,566
Accruals and Deferred Income
27,754
108,816
-145,814
70,985
128,219
-164,182
133,711
29,021
210,824
Deferred Taxes & Provisions
16,380
16,380
2,730
Cash flow from operations
-197,985
545,122
-14,203
104,467
-23,248
-221,846
796,187
60,848
-94,046
-165,278
-518,660
-221,554
-356,723
139,935
3,184
Investing Activities
capital expenditure
-19,210
-43,724
-319,772
-53,780
-21,632
-21,433
-26,519
-37,078
-44,698
-21,618
-18,226
-989
-1,751
-473
-4,851
Change in Investments
cash flow from investments
-19,210
-43,724
-319,772
-53,780
-21,632
-21,433
-26,519
-37,078
-44,698
-21,618
-18,226
-989
-1,751
-473
-4,851
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
4
60
-24
712,222
510,293
279,770
472,576
500,000
6,860
1,667
interest
31,246
39,170
11,956
1,729
1,368
8,635
4,408
1,205
1,416
250
178
892
1,090
367
cash flow from financing
31,250
39,170
12,016
1,705
713,590
8,635
4,408
1,205
511,709
280,020
472,754
892
501,090
7,227
1,667
cash and cash equivalents
cash
370,081
-1,023,048
-321,959
52,391
668,710
-234,644
774,076
24,975
372,965
93,124
-64,132
-221,651
142,616
146,689
overdraft
change in cash
370,081
-1,023,048
-321,959
52,391
668,710
-234,644
774,076
24,975
372,965
93,124
-64,132
-221,651
142,616
146,689
fios genomics limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for fios genomics limited. Get real-time insights into fios genomics limited's credit score, group structure and payment trends.
Perform a competitor analysis for fios genomics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EH16 area or any other competitors across 12 key performance metrics.
fios genomics limited Ownership
FIOS GENOMICS LIMITED group structure
Fios Genomics Limited has no subsidiary companies.
Ultimate parent company
FIOS GENOMICS LIMITED
SC341432
FIOS GENOMICS LIMITED Shareholders
The largest shareholders in Fios Genomics Limited include Scottish Enterprise and Charles River Discovery Research Services Uk Limited.
scottish enterprise
20.54%
charles river discovery research services uk limited
9.97%
executors of the estate of the late peter ghazal
5.75%
thomas charles freeman
5.75%
alastair eric hotson salvesen
3.67%
gavin john norman gemmell
3.36%
the helen sealey testamentary trust
3.2%
james gordon dickson ferguson
2.62%
geoffrey arthur ball
2.1%
brian james duffin
1.92%
fios genomics limited directors
Fios Genomics Limited currently has 5 directors.
The longest serving directors include
Dr Alistair Strachan (Feb 2012) and
Dr Sarah Lynagh (May 2013).
72110 - Research and experimental development on biotechnology
incorporation date
April 2008
age
17
incorporated
UK
ultimate parent company
None
accounts
Group
last accounts submitted
April 2024
previous names
mbm shelfco (54) limited (May 2008)
accountant
-
auditor
FRENCH DUNCAN LLP
address
13 little france road, edinburgh bioquarter, edinburgh, EH16 4UX
Bank
BANK OF SCOTLAND
Legal Advisor
MBM COMMERCIAL LLP
fios genomics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to fios genomics limited. Currently there are 1 open charges and 1 have been satisfied in the past.
fios genomics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for FIOS GENOMICS LIMITED. This can take several minutes, an email will notify you when this has completed.
fios genomics limitedCompanies House Filings - See Documents
